Micro Labs, Sun Pharma, Cipla & Glenmark are in race for coveted Leadership Award in Healthcare

India’s Most Valuable Pharmaceutical Company

 

3^rd Annual Indian Affairs Business Leadership Awards 2011 Will Test The Leadership Of Domestic Pharma Majors Micro Labs, Sun Pharma, Cipla & Glenmark For The Coveted “India’s Most Valuable Pharmaceutical Company”As Their Performance & Leadership In Key Therapeutics Segments Will Be Judged & Voted By The Indian Medical Doctors.

 

Maharashtra , Mumbai, Thursdayday, February 23, 2012 : It is a matter of both pride & testing time for the top 4 major Pharmaceutical Companies in India such as Micro Labs, Sun Pharma, Cipla & Glenmark as these Companies have been nominated by Indian Affairs Business Leadership Awards 2012 at the 3^rd Annual India Leadership Conclave hosted by India’s pink Magazine Indian Affairs ( www.indianaffairs ) in partnership with India’s Most widely read Analytical & interactive Pharmaleaders Magazine ( www.pharmaleaders.co.in ) who is assigned to do a comprehensive market survey of Indian Medical Doctors to choose the best. According to MCI’s Indian Medical Register that was last updated in April 2011, the nation supposedly boasts of 840,678 registered medical practitioners & the Indian healthcare industry is seen to be growing at a rapid pace and is expected to become a US$280 billion industry by 2020. Rising income levels and a growing elderly population are all factors that are driving this growth. In addition, changing demographics, disease profiles and the shift from chronic to lifestyle diseases in the country has led to increased spending on healthcare delivery.In order to meet manpower shortages and reach world standards India would require investments of up to $20 billion over the next 5 years.

Given the enormous opportunities & global exposure, It is pertinent here to note that India is all set to emerge as one of the Top 5 global markets for pharmaceutical products by 2020, driven by huge domestic demand and increased consumer spending on drugs & the global pharma market is expected to grow at 7 percent to 8 percent over the next five years, reaching an anticipated $1.7 trillion in 2020. with the rise in the per capita income, the spending is going to be triple (approximately $33) by 2020 & By 2020, nearly 650 million people will have health insurance cover, while private insurance coverage will grow by nearly 15 percent annually till 2020. A close study on Indian market has revealed that in metros and Tier-1 markets, which have been growing at 14-15 percent in the last five years, will drive growth in the industry. They account for 60 percent of the Indian pharmaceutical market today and look set to continue growing to a market size of $33 billion by the end of the decade, rural areas, on the other hand, will constitute 25 percent of the total market, by 2020, up from 20 percent at present.

The sample size of the Pharmaleaders Research team comprise of nearly 12,000 Doctors in Tier1 Tier 2 Cities who have access to internet & use emails on a regular basis. As the methodology involve voting by email, physical answers & mostly smses, these doctors are asked whom will they choose as their best partner while treating patients & administering the drugs on them. While Cipla is a old player & familiar name to these doctors, other three nominees such as Microlabs, Glenmark & Sun Pharma have dominated the indian prescription market & come to the centre stage lately with strong marketing, R &D with a focus on manyfacturing facilities. The total Medical Representatives employed by Micro Labs, Sun Pharma, Cipla & Glenmark are more than 10,000 while Microlabs alone  is believed to have a strong force of 3000 Medical Representatives. Ranking 10th among prescriptions and 20th in sales, Micro’s brand portfolio includes some of the topmost brands in various specialties like Cardiology, Diabetology, Anti-infectives, Ophthalmology, Pain, etc. Cipla, Glenmark & Sun Pharma too come under the top 20 categories. Sun Pharma is a consistent performer & has outsmarted other companies by sales & figures while Glenmark is sound in Research & strong in dermatology segments. Cipla’s products are also widely patronized by Indian Doctors.

Amidst the above back-ground, all four leading national players will be tested & diagnosed by the Doctors who will choose the coveted “India’s Most Valuable Pharmaceutical Company 2012”. The Winner will be announced on at the Asia’s Biggest & India’s Much awaited 3rd Annual India Leadership Conclave & Indian Affairs Business Leadership awards 2012 in Bengaluru, Friday, the 6th April 2012 at the Grand Ball Room of Hotel Lalit in India.

IND-SWIFT Forges Partnership with ROCHE DIAGNOSTICS to expand TROP T Rapid assay in India

Troponin-T is used to measure damage to the heart muscle and to differentiate between non- cardiac chest pains and heart attacks.

Roche Diagnostics India Pvt. Ltd. enters into an agreement with Ind-Swift Limited; a Chandigarh based pharmaceutical company to promote its test for detecting heart attack, TROP T rapid assay, in India. Roche Diagnostics India Pvt. Ltd. is part of Roche Group, a worldwide leader in the field of Medical Diagnostics and Pharmaceuticals. Roche Diagnostids’ TROP T rapid assay is a point of care test which can detect whether a patient is having a heart attack through a simple whole blood test.

Dr. G Munjal, managing director and CEO, Ind-Swift with Roche

Troponin-T is used to measure damage to the heart muscle and to differentiate between non-cardiac chest pains and heart attacks. The TROP T rapid assay gives a reliable qualitative result within 15 minutes. Ind-Swift Ltd. has a Cardio Specific Field Force, CARDIASWIFT which has been marketing cardio & anti-diabetic products for the last 8-10 years. Over the years, CARDIASWIFT has established a sound presence in the minds of cardiac and diabetic specialists and consulting physicians. Ind-Swift Limited will promote TROP T to cardiologists / diabectologists / consulting physicians/general practitioners all over the country with its 225 Strong Field Force. This collaboration with Roche Diagnostics India Pvt. Ltd. will give ISL a big chance to develop a strong presence in the cardiac field with some of the most established and renowned specialists and hospitals”, said an elated Dr. Gopal Munjal, M.D & C.E.0, Ind-Swift Group.

Speaking on the occasion, Dr. Bhuwnesh Agrawal, Chairman and Managing Director, Roche Diagnostics India and South Asia said, “With a strong commercial partner like Ind-Swift Limited we are confident to penetrate in our target markets and reach out to doctors and patients throughout India and therewith reduce the burden of cardiovascular mortality in our country”. Reforms Espoused In Education System

Polytechnic education and industrial training commissioner Mrs. Usha R Sharma addressing a gathering during a panel discussion at PHD Chamber in Sec-31, Chandigarh, on Friday. A daylong discussion on the subject ‘Are Reforms required in the Education System in India’ organised by the Indo-Swift evoked thought-provoking and pragmatic deliberations. Stressing the need to give education a broader connotation than it being mere literacy, the speakers, most of them educationists, supported the idea of finishing school of education. Mrs. Usha R Sharma, commissioner, polytechnic education and industrial training, chaired the function. The other panelists included Dr. SS Gill, vice-chancellor, Baba Farid University of Health Sciences;Mr. DK Dhawan, professor of department of biophysics, Panjab University; and Videocon vice-president Mr. Prem Ojha. Mr.Vivek Atray, additional transport commissioner, Haryana, was the moderator for the event.

IND-SWIFT  is Chandigarh based pharmaceutical company, established in 1986 with a mission of winning global customers through innovative pharmaceutical products. Three visionaries Jains, Mehtas and Munjals, dedicated themselves to work for humanity’s quest for longer, happier and healthier lives . IND-SWIFT has been ranked 35th among top Indian Pharmaceutical companies. IND-SWIFT is ISO 9001-2008, WHO GMP certified  and is listed on Bombay Stock Exchange and National Stock Exchange . We ensure value for money by developing innovative, therapies and process to produce safe effective and consistent quality pharmaceutical products  delivering across the globe. IND-SWIFT is a research driven forward looking pharmaceutical company having world class expertise in finished goods dosage and active pharmaceutical ingredients (API’s)and herbal products. IND-SWIFT is proud to be the second largest drug manufacturers  of  North India. IND-SWIFT’S multipurpose, multilocation manufacturing set-ups are spread across the lush-green plains of northern India. The facilities are built according to current guidelines of MHRA, EU, WHO, and accreditations with ISO 14000 series standards.With strong network presence in more than 45 countries we are committed to provide quality medicines and better health care.  The company  has dedicated research and development department well equipped with the latest equipments and supported by a large pool, of scientists who continuously work towards new pharma products. Apart from being among top indian pharma companies, IND-SWIFT has also progressively embarked in diversification into multifarious fields viz Infrastructure, Printing Packaging and Stationery, Education, and Media Publication with its every unit as an independent profit earning centre. Mrs. Usha advocated counseling of the students at an initial stage in schools itself, in terms of the career option they wanted to choose. “Proper education and career of choice would enhance students’ productivity,” she added. Mr.Atray said the purpose of education is to ultimately prepare students to compete and grow in the professional world so it should involve real-world exposure and activities. Mr.Ojha said practical and feasible ways for better education are by arrainging frequent interactions with experts or role models from industry or other fields. Mr.Dhawan said foreign direct investments must be encouraged in educational institutes for exposure to fair competition and international faculty.

Dr. G Munjal, managing director and CEO, Ind-Swift, espoused the need for finishing schools where the students can be transformed into the best product in terms of individual personalities and contributing elements to society. He concluded the discussion by saying that stern rules and regulations and their strict implementation could usher in positive results in government and private educational institutes. The purpose of education is to ultimately prepare students to compete in professional world, so it should involve real-world exposure.

Industry Leaders come together At 3rd Annual India Leadership Conclave 2012 to to brainstorm on “Brand India – The Emerging Super Power

Industry Leaders come together At 3^rd Annual India Leadership Conclave 2012 to to brainstorm on “Brand India – The Emerging Super Power

M.D. Mallya of Baroda, Captain Gopinath of Deccan Aviation, Sushil Karwa of  Krishidhan Seeds Group, Ajit Joshi of Infiniti Retail Limited, Croma, Dr Kannan Vishwanathan of Anjaneya Lifecare, Vijay Kalantri of Balaji Infraprojects,  Paritosh Joshi of  STAR CJ Network, Shailendra Singh of Percept India, Dr BR Jagashetty, Drugs Controller of Karnataka, François Licoppe of   Eubage Laboratory Sprl, Belgium, Naveen Surya of Itz Cash Card & Ashish Agarwal of Onco Life Sciences among others to debate at Asia’s Biggest Conclave

Maharashtra, Mumbai, India, Saturday, Feb 18, 2012: 3^rd Annual India Leadership Conclave & Indian Affairs Business Leadership Awards 2011 hosted by Indian Affairs in association with leading Industry Associations is getting bigger & bigger as India’s topmost Leaders & influential powerful voices who have been responsible for building brands in their respective Industries are going to debate on multiple issues & complex agendas concerning India’s branding at the world perspectives. These Shining Stars of the Corporate world are expected to throw new dimensions on various challenges, India, is currently facing & the opportunities ahead in the near future. “It is no wonder, in a free economy, increasing business relationships, trade & collaborations of many indian Brands with overseas players, Indian Brands have established a envious & indomitable position in the world Market” said Satya Brahma, who is chairing the 3^rd Annual India Leadership Conclave & Indian Affairs Business Leadership Awards in three successive years. “The coming together of these industry Leaders & deliberating on “Brand India – The Emerging Super Power, Limitless Leadership, Limitless Possibilities” at the 3^rd Annual India Leadership Conclave platform will hopefully bring out crucial innovative solutions to some of the challenges hitherto unexplored said Satya Brahma in a news release today.

The list of Industry Leaders to debate on the topics such  are as Indian “IT Sector : The Ghost of Recession & Global Outsourcing – The Road Ahead”, “Re-inventing Brand India’s  Low Cost Carrier : A Missed Opportunity & The Way Forward”, “Ecommerce and Digital Payments Challenges and Opportunities”, “Agriculture – New Directions & New Paradigms, “Seed to Farm Gate to Fork”, “Policy Reforms, Strong Legislations for Indian Healthcare Industry : The Way Forward”, “Neutraceutical & OTC   Sector : The European Market Challenge”, “Globalization of Indian Biotech Innovations: Key Challenges & Opportunities”, “Dynamics of Indian Banking Sector : Branding Indian Banking Globally, key issues and challenges in managing Waste to energy project  in India”, “key issues and challenges in managing infrastructure projects in India etc will be deliberated by Industry leaders like Mr. Naveen Surya, Managing Director, Itz Cash Card Ltd, Sushil Karwa, MD, Krishidhan Seeds Group, BR Jagashetty, Drugs Controller, government of Karnataka, Paritosh Joshi, CEO, STAR CJ Network India Pvt. Ltd, François Licoppe,CEO,  EUBAGE LABORATORY SPRL, Belgium, Ajit Joshi, CEO & MD, Infiniti Retail Limited, Croma A Tata Enterprises, Ashish Agarwal. CEO & MD, Onco Life Sciences Pvt. Ltd, Vijay Kalantri, President, All India Association of Industries (AIAI), CMD, Balaji Infra Projects Limited, Mr.M.D. Mallya, CMD, Bank of Baroda Ltd.

Coinciding with 3^rd Annual India Leadership Conclave, Indian Affairs Business Leadership Awards 2012 has as many as 30 categories who will be voted by the country via sms & emails are the top leaders & Corporate Industry sectors. 3rd ANNUAL INDIA LEADERSHIP AWARDS 2012 Award Categories

NOMINEES

1. Business Leader of The Year

• G.R.K.Reddy, CMD, Marg Group.
• Nirmal Jain, chairman of IIFL.
• Dr Kannan Vishwanath, MD, Aanjaneya Lifecare
• Rajan Anandan ,Managing Director ,Google India Ltd.

2. Businesswoman of the Year

• Vinita Bali, Managing Director, Britannia Industries
• 2.Neelam Dhawan, Managing Director, HP,India
• 3.Preetha Reddy, Managing Director of Apollo Hospitals
• 4.Ekta Kapoor, creative head of Balaji Telefilms.

3. India’s Most Valuable 4 Wheeler Brand

• 1.Hyundai EON
• 2.Maruti Swift Dzire
• 3.Renault Pulse
• 4.Volkswagen Polo

4. India’s Most Valuable Private Bank

• Karnataka Bank
• ICICI Bank
• ING Vysya Bank Ltd
• Yes Bank Ltd

5. India’s Most Valuable Public Bank

• State Bank of India
• Punjab National Bank Ltd
• Bank of Baroda Ltd
• Allahabad Bank Ltd.

6. India’s Most Valuable IT Software Company

• 1.Infosys Technologies Ltd
• 2.HCL Technologies Ltd
• 3 Wipro Ltd
• 4 Mindtree Ltd

7. India’s Most Valuable Agricultural Biotech Company

• 1.Monsanto India Limited
• 2.Camson Bio Technologies Limited
• 3.Krishidhan Seeds Pvt. Ltd
• 4.Monsanto India Limited.

8. India’s Most Valuable Telecom Company

• Bharti Airtel Ltd
• Idea Cellular Ltd
• Aircel Cellular Ltd
• Vodafone India Ltd.

9. India’s Most Valuable IT & Web Solution Provider Company

• DotCom Services India Pvt. Ltd
• General Data Pvt Ltd.
• Leafgrafica
• Seeknext IT Solutions Pvt .Ltd

10. India’s Dynamic Entrepreneur of The Year

• 1.Anil K. Agarwal, CMD, Cosmos International Ltd.
• 2.Mr. Sushil Karwa, MD, Krishidhan Seeds
• 3.Irfan Razack, CMD, Prestige Group
• 4.Kunal Bahl, CEO, Snapdeal.com

11. India’s Most Valuable English Broadcast Electronic Media.

• 1.Cnn Ibn
• 2.Times Now
• 3.Ndtv 24/7
• 4.Headlines Today

12. CEO  of the year.

• 1.Mohit Anand, MD  – Indian Sub Continent, Belkin
• 2.Hari Krishnan, Country Manager,LinkedIn India
• 3.Dr Kannan Vishwanath, MD, Aanjaneya Lifecare
• 4.Aditya Mittal, CFO, ArcelorMittal

13. First Generation Entrepreneur of the year

• 1.Atul Punj,Chairman , Punj Lloyd Group
• 2.Alok Mittal, Managing Director at Canaan Partners.
• 3.Girish Batra,  Chairman, NetAmbit ValueFirst Service Limited
• 4.Ashish Agarwal, Managing Director, ONCO Life Sciences Pvt. Ltd.

14. Healthcare Professional of The Year

• Dr B R Jagga Shetty Drug Controller of Karnataka.

15. India’s Most Valuable Telecom Company

• Bharti Airtel Ltd
• Idea Cellular Ltd
• Aircel Cellular Ltd
• Vodafone India Ltd.

16. Outstanding Contribution to Indian Cinema

Dr. Girish Karnad.

17. India’s Most Valuable Pharmaceutical Company

• Cipla Ltd
• Glenmark Pharmaceuticals Ltd
• Microlabs Ltd
• Sun Pharmaceutical Industries Ltd.

18. India’s Most Valuable Actress in Indian Cinema

• 1.Anushka Sharma.
• 2.Kareena Kapoor
• 3.Katrina Kaif
• 4.Priyanka Chopra

19.India’s Most Valuable E-Commerce Company of the year

• E-Billing Solutions Pvt Ltd.
• Itz Cash Card Ltd
• Jasper Infotech Pvt Ltd
• STAR CJ Network India Pvt Ltd

20. Deal Maker of The Year 2012

• 1.Ashish Kashyap, CEO – ibibo Group
• 2. Manu Agarwal , Founder and CEO at Naaptol.com
• 3 Paritosh Joshi , Chief Executive Officer at STAR CJ Network India Pvt Ltd
• 4. Kunal Bahl , CEO, Snapdeal.com

21.India’s Most Promising & Valuable Infrastructure Company

• GMR Infrastructure Limited
• Balaji Infra-Projects Limited
• Hindusthan Infrastructure Projects and Engineering Pvt Ltd.
• Soma Enterprises Limited.

22. India’s Most ValuableBrand of The Year 2012

• Percept
• Microsoft India
• Nokia india.
• Revital
  

  3rd Annual India Leadership Conclave Speakers

Prestigious 3rd Annual India Leadership Conclave 2012 Award Nominations Announced

Satya Brahma, Chairman, 3rd Annual India Leadership Conclave 2012

G.R.K.Reddy of  Marg Group, Nirmal Jain of IIFL, Dr Kannan Vishwanath of  Aanjaneya Lifecare , Rajan Anandan ,of Google India  are in the race for coveted Business Leader of the Year while Vinita Bali of Britannia Industries, Neelam Dhawan of HP,India, Preetha Reddy of Apollo Hospitals & Ekta Kapoor of Balaji Telefilms are nominees for Business Woman of the Year 2012

 

Maharashtra , Mumbai, Monday, February 13, 2012 : After being highly successful consecutively for two years, the third Annual India Leadership Conclave & Indian Affairs (www.indianaffairs.in ) Business Leadership Awards 2012 ( www.indialeadershipconclave.com ) is all set to mark its dent in the silicon valley of Bangalore on 6^th April, on Friday at Hotel lalit 2012. India Leadership Conclave is one of Asia’s biggest leadership event where the who’s & who’s of corporate india will assemble to discuss the changing fabric of Indian business, brands & business dynamics & its enviable position in the global market. Organized by Indian Affairs, India’s first pink news magazine, the third Annual India Leadership Conclave with an aptly theme of “Brand India – The Emerging Super Power, Limitless Leadership, Limitless Possibilities”, the Annual Event will witness more than 15 business Leaders to debate on Brand India & its limitless possibilities. While more than 200 powerful think tank of the society will attend the annual event, 3^rd Annual India Leadership Conclave & Awards 2012 is expected  participation from the business community from Europe, Middle East & Asean countries.

Touted to be the most prestigious event in Asia, The Conclave aim to create a strong platform for interaction amongst the leaders of today & tomorrow. Entering in its 3^rd year, the much anticipated nomination categories for the 3^rd Annual India Indian Affairs Leadership Business Leadership Awards  2012 is announced today with as many as 30 categories in various fields such as Agriculture, Automobiles, Auto Components, Aviation, Education and Training, Engineering, Financial Services, Food Industry, Insurance, IT & ITeS, Manufacturing, Media and Entertainment, Retail, Science and Technology, Banking, Biotechnology, Cement, Consumer Markets, Healthcare, Infrastructure, Oil and Gas, Pharmaceuticals, Real Estate & Infrastructure, Steel, Textiles, Telecommunications, Tourism and Hospitality will be recognized for their outstanding contribution to the Indian Industry. Commenting on the announcement, Satya Brahma, Chairman of 3^rd Annual India Leadership Conclave & Indian Affairs Business Leadership Awards 2012 said, “We attempt to recognize the shining stars of brand India through a credible Award mechanism where each nomination has four nominees judged by the eminent juries & are thrown upon to public for three-tier votings through sms & email votings & finally by the Juries verdict”.  “This years nominations are blending with young blood with veterans while a lot of emphasis has been given to the SME sectors which are often neglected due to the presence of big personalities & brands” he added.

The Nominees for 3^rd Annual India Leadership Indian Affairs Business Leadership Awards are as follows.

Business Leader of  The Year 2012

1. G.R.K.Reddy, CMD, Marg Group.

2. Nirmal Jain, chairman of IIFL.

3. Dr Kannan Vishwanath, MD, Aanjaneya Lifecare

4. Rajan Anandan ,Managing Director ,Google India Ltd.

Businesswoman of the Year 2012

1. Vinita Bali, Managing Director, Britannia Industries

2.Neelam Dhawan, Managing Director, HP,India

3.Preetha Reddy, Managing Director of Apollo Hospitals

4.Ekta Kapoor, creative head of Balaji Telefilms.

CEO  of the Year 2012

1.Mohit Anand, MD  – Indian Sub Continent, Belkin

2.Hari Krishnan, Country Manager,LinkedIn India

3.Dr Kannan Vishwanath, MD, Aanjaneya Lifecare

4.Aditya Mittal, CFO, ArcelorMittal

First Generation Entrepreneur of the Year 2012

1.Atul Punj,Chairman , Punj Lloyd Group

2.Alok Mittal, Managing Director at Canaan Partners.

3.Girish Batra,  Chairman, NetAmbit ValueFirst Service Limited

4.Ashish Agarwal : Managing Director, Nco Life Sciences Pvt. Ltd

India’s Most Valuable English Broadcast Electronic Media.

1.Cnn Ibn

2.Times Now

3.Ndtv 24/7

4.Headlines Today

India’s Most Valuable 4 Wheeler Brand

1.Hyundai EON

2.Maruti  Swift Dzire

3.Renault Pulse

4.Volkswagen Polo

India’s Most Valuable Private Bank

1. Karnataka Bank

2. ICICI Bank

3. ING Vysya Bank Ltd

4. Yes Bank Ltd

India’s Most Valuable Public Bank

1. State Bank of India

2. Punjab National Bank Ltd

3. Bank of Baroda Ltd

4. Allahabad Bank Ltd.

India’s Most Valuable IT Software Company

1.Infosys Technologies Ltd

2.HCL Technologies Ltd

3 Wipro Ltd

4 Mindtree Ltd

India’s Most Valuable Agricultural Biotech Company

1.Monsanto India Limited

2.Camson Bio Technologies Limited

3.Krishidhan Seeds Pvt. Ltd

4.Monsanto India Limited.

India’s Most Valuable Telecom Company 

1. Bharti Airtel Ltd

2. Idea Cellular Ltd

3. Aircel Cellular Ltd

4. Vodafone India Ltd.

India’s Most Valuable IT & Web Solution Provider Company

1. DotCom Services India Pvt. Ltd

2. Adodis Technologies

3. Leafgrafica

4. Seeknext IT Solutions Pvt .Ltd

India’s Most Valuable Real Estate Company 2012

1. Provident Housing Ltd.
2. Mantri Developers Pvt Lrd.
3. Prestige Estate Projects Ltd.
4. Marg Properties. ( Marg Group)

Four Finalists Will Be Selected For Each Award. Finalists Will Be Notified Prior To The Event By Email. The Winners Will Be Announced During The Award Night , On Friday, April 6th 2012 At The Grand Ball Room, Hotel Lalit, Bengaluru, India. These  Award Will Honour An Individual /Corporate Who Is Seen As A Trusted Guide, Influential Mentor And A Strategic Executive, Instrumental In The Successful Turnaround Of Her Company. She Must Have Played A Pivotal Role In The Company’s Success, Adding To A Career Of Extraordinary Performance And Exceptional Results. The Award Will Recognise An Exceptional Leader Who Has Played An Important Role In Her Specific Sector Development, On Various Levels. The Individual Should Have Demonstrated Initiative While Serving Consumer Needs, Implemented Innovative Strategies In Order To Improve Performance, And Contributed To The Growth Of The Community And Environment, As Well As The Region.

Bengaluru to host the prestigious 3rd Annual India Leadership Conclave 2012

Bengaluru to host the prestigious 3^rd Annual India Leadership Conclave 2012

Asia’s Biggest & India’s Much awaited 3^rd Annual India Leadership Conclave & Indian Affairs Business Leadership awards 2011 to focus on Brand India

Maharashtra, Mumbai, India, Wednesday, Feb 8, 2012 : Indian Brands are as crazy as is its innovators are, as Indians constantly innovate. A close scrutiny of Indian Brands post the free economy era will reveal that large number of players in diverse sectors have made their mark in their respective fields notwithstanding the hurdles & government regulation from time to time. Today Brand India is globally accepted as the world Market is looking at india as the most preferred destination for collaboration, partnerships & investments. India is a land of billion opportunities and not a billion problems . In the last 20 years, the country has added a trillion dollars of output. The last decade has seen India emerge stronger on the world map, especially during the global financial meltdown when the country weathered the crisis much to the admiration of the world. India today stands poised at the threshold of change. India, today, has emerged as one of the decisive nations shaping the contours of the world economy. Consistently charting a growth path over the last few years, Brand India is an idea whose time has truly arrived. Today, the triumph of Brand India is visible in almost all fields. With some aggressive cross-border acquisitions, India has been rewriting the global business equations; India has established its leadership in IT and knowledge-based industries globally and has the fastest growing population of workers and consumers. With huge investments in infrastructure development on the anvil, India today is a preferred investment destination. It has one of the world’s most rapidly growing markets, and today, Indian products and services are recognised for their quality all over the world.

Against the backdrop of the above backgrounder, where Brand India matters most, Indian Affairs(www.indianaffairs.in) , India’s first pink Magazine is hosting the high profile & india’s most eagerly awaited leadership event, the 3^rd Annual India Leadership Conclave & Indian Affairs Business Leadership Awards 2012 in association with the Ministry of Corporate Affairs, Government of India on Friday, 6^th April at Hotel Lalit, Bengaluru, India. Keeping its tradition of bringing the finest think-tanks of the society from the different diverse sectors like the much acclaimed two Annual Events ( 1^st Annual India Leadership Conclave( www.ilcbusinessleaders.com ) in Delhi & 2^nd Annual India Leadership Conclave( www.indialeadershipconclave.in ) in Mumbai), the stage is set for the third one under the theme “ BRAND INDIA – THE EMERGING SUPER POWER, LIMITLESS LEADERSHIP, LIMITLESS POSSIBILITIES.Announcing the Event, satya Brahma, Chairman & editor-In-chief of Indian Affairs magazine said “ 3^rd Annual India Leadership Conclave 2012 will bring into forefront the critical issues & will seek to debate how the Brand India has moved over the years by the elite speakers”.  More than 200 Industry stalwarts from who’s & who’s of India’s core diverse sectors such as Agriculture, Automobiles, Auto Components, Aviation, Education and Training, Engineering, Financial Services, Food Industry, Insurance, IT & ITeS, Manufacturing, Media and Entertainment, Retail, Science and Technology, Banking, Biotechnology, Cement, Consumer Markets, Healthcare, Infrastructure, Oil and Gas, Pharmaceuticals, Real Estate & Infrastructure, Steel, Textiles, Telecommunications, Tourism and Hospitality will attend the Annual Leadership Conclave. The Conclavewill have the powerful voices from the stalwarts of the Indian inc on topics of tremendous significance on Indian Inc’s complex issues.

3rd Annual India Leadership Conclave Award Categories – 2012.

 

1. 1.      India’s Most Valuable Private Bank :
2. 2.      India’s Most Valuable Public Bank
3. 3.      India’s Most Promising & Valuable Infrastructure Company
4. 4.      India’s Most Valuable 4 Wheeler Company
5. 5.      BusinessLeader of the Year
6. 6.      BusinessWoman of the Year
7. 7.      India’s Best Managed Hospitality Group
8. 8.      India’s Most Valuable IT & Web Solution Provider Company
9. 9.      India’s Most Promising Real Estate & Infrastructure Company
10. 10.   India’s Most Valuable & Best Managed Medical Tourism Company
11. 11.  Innovative CEO of The Year
12. 12.  Excellence in Social Service
13. 13.  India’s Dynamic Entrepreneur of The Year 
14. 14.  India’s Most Valuable IT Software Company
15. 15.  India’s Most Valuable Telecom Company 
16. 16.  India’s Most Valuable Consumer FMCG Company 
17. 17.  India’s Most Valuable IT Global Career Company for Masses
18. 18.  India’s Most Valuable Pharmaceutical Company
19. 19.  India’s Most Promising Retail Pharmacy Company
20. 20.  India’s Most Valuable Energy Company
21. 21.  India’s Most Valuable Legal Firm 
22. 22.  Outstanding Contribution to Indian Cinema 
23. 23.  India’s Most Valuable Broadcast  Electronic Media.
24. 24.   India’s Most Promising Agricultural Biotech Company.
25. 25.   Social Enterprise of the Year
26. 26.   Outstanding Contribution to Indian Cinema :  Actress of the Substance.
27. 27.   First Generation Entrepreneur of the year Award
28. 28.   Best Retailer of the Year
29. 29.   Global Indian Achievers Award
30. 30.   India’s  Most Valuable Business School of the Year :

Union Budget 2012-13 should promote investment oppourtunities on Agriculture and Biotech sector – Sushil Karwa, MD, Krishidhan Seeds.

Union Budget 2012-13 should promote investment oppourtunities on Agriculture and Biotech sector – Sushil Karwa, MD, Krishidhan Seeds..

Union Budget 2012-13 should promote investment oppourtunities on Agriculture and Biotech sector – Sushil Karwa, MD, Krishidhan Seeds.

Union Budget 2012-13 should promote investment oppourtunities on Agriculture and Biotech sector – Sushil Karwa, MD, Krishidhan Seeds.

 

Essential Quality Seeds need top priority for seed Rsearch and seed companies should be given a status of infrastructure companies.

 

Maharastrha, Mumbai, Friday, 3^rd Jan2012 : Krishidhan Seeds KSPL which  focuses on Agriculture and Biotech sector told Network 7 Media Group’s Indian Affairs Magazine ( www.indianaffairs.in ) & Pharmaleaders Magazine (www.pharmaleaders.co.in )that as it is one of the top three seed companies which is actively involved in research, production, processing, packing, and marketing of high quality seeds of Cotton, Cereals, Pulses, Oil seeds and Vegetables. Speaking to explain its expectations from the Union Budget 2012-13, Mr. Sushil Karwa, MD, Krishidhan Seeds emphasized that “For enhancing the agricultural yield, quality seeds are most essential. In India, farmers are still struggling to get quality seeds because there is no encouragement for seed companies to invest in seed research. To promote seed research, seed companies should be given a status of infrastructure companies and income of seed companies should be treated as agri. income. Finance extended to seed companies should be treated as priority sector lending in the banks. Govt. is extending various subsidies for distribution of oil seeds, pulses seeds, hybrid paddy seeds etc. only to Govt. owned seed corporations. This makes private seed companies uncompetitive. Hence, private seed companies are not investing desirable resources in this segment, because of which, the productivity is stagnant in these crops. Subsidies should be extended to private seed companies also.Price deregulation, particularly in cotton is essential otherwise new technology will not come to India as there is no price differentiation between good & bad”.

It may be recalled that Krishidhan Seeds is one of the fastest growing and amongst the top three seed companies in India with National and International presence. The Group focuses on ushering prosperity of the farming community both at National and International level. The company is actively involved in research, production, processing, packing, and marketing of high quality seeds of Cotton, Cereals, Pulses, Oil seeds and Vegetables. The R&D activities and research stations of Krishidhan are recognized by the Department of Scientific and Industrial Research (DSIR), Govt. of India.

Mr. Sushil Karwa, MD, Krishidhan Seeds expressed hopes that the Union Budget will take into consideration the growing demands of Seeds & Agriculture Companies to promote Farmer’s Research to boost the efficiency of quality seeds. He further stated that the Seeds Companies which are involved in Biotech Research must be given special priorities as agriculture in india is the biggest sector.

 

Dr. Kannan Vishwanath Led Aanjaneya Lifecare buys Apex Deugs valued at Rs 250 crore

Dr. Kannan Vishwanath Led Aanjaneya Lifecare buys Apex Deugs valued at Rs 250 crore

 

Pharma Acquisition rolls on SMES as to Increase Financial & product portfolio

 

 

Pharmaleaders Magazine reported a news story on 31^st Jan 2012 that Aanjaneya Lifecare is close to acquire a domestic Pharma Company & On 2nd February 2012, Aanjaneya Lifecare declared the completion of the acquisition of Apex Drugs and Intermediates Ltd (ADIL), an integrated API and pharma intermediates manufacturing company based in Hyderabad. The acquisition was valued at Rs. 250 crore ; with Debt of Rs. 185 crores and equity dilution of Rs. 65 Crores.

Aanjaneya  Lifecare Ltd has acquired ADIL’s assets, businesses, clients, licensees, employees and has merged both the companies’ operations, becoming a fully integrated formulation company. The company will also leverage the strong relations of ADIL developed in Asia, Europe, UAE & Latin America for exports. The acquistion also gives Aanjaneya an entry in Hyderabad market. Post acquisition Aanjaneya Lifecare will have approximate sales of Rs.700 crores with EBITDA of Rs.130 crore and total long term debt in books of about Rs.220 crore against networth of Rs. 365 crore. (The company’s debt to equity ratio would be less than 1). In monetary terms, Aanjaneya Lifecare can sell 40% of the APIs into formulations and formulation sales would be three times the API sales.

The acquisition would widen the footprints of the company through its easy access to the product portfolio of ADIL and enable it to cross–sell the products to ADIL’s customer base. The product portfolio of Aanjaneya Lifecare will be widened by ADIL’s API business of Aids, HIV, Diabetes, Ace inhibitors and CNS. The acquisition has saved time that would have taken 3-4 years time to secure clearances.

Aanjaneya Lifecare with its strong presence in API and formulation business, the company in future also plans to expand its product portfolio to lifestyle segment. This will enable the company to have diversified product portfolio which will help it to become a fully integrated formulation company.

Commenting on the acquisition of Apex Drugs and Intermediates, Dr. Kannan Vishwanath, Vice Chairman and Managing Director of Aanjaneya Lifecare Ltd said,” We are very pleased to announce the acquisition of Apex Drugs and Intermediates Ltd (ADIL).It will reduce the company’s dependence on third parties for pricing and supply to a large extent.Going further the company also plans to enter into lifestyle segment. The acquisition will not only strengthen Aanjaneya Lifecare’s presence in the Hyderabad market but would also expand its stronger growth footprint in their market”.

India has been ranked as the fourth most attractive nation for retail investment among 30 emerging markets by the US-based global management consulting firm

Consumer Markets in India: Brief Overview

Indians are amongst the world’s most positive clan when it comes to job prospects and personal finances, according to Nielsen’s Global Online Consumer Confidence second quarter of 2011. Higher brand awareness, increase in disposable incomes, availability of wider options in markets, changing lifestyle and demographics are some of the major drivers, among others, that have propelled Indian consumer markets over the last decade. The progress can also be largely attributed to calculative liberalised policies implemented by the government that have not only encouraged foreign companies to foray into India, but have also taken care of domestic players and their growth.

 

Consumer Markets in India: Some Statistics

Certain numbers that indicate elevation of lifestyles among Indians, that has driven consumerism directly or indirectly, are given below:

• Percentage of Indian households (both rural and urban) with electricity for domestic use showed a significant increase from 64 per cent in 2002 to 75 per cent in 2008-09, as per the report prepared by the Institute for Applied Manpower Research under the Planning Commission.
• Confirming that the expenditure on non-food items like durable goods has increased over the past few decades, a report by National Sample Survey Office (NSSO) has revealed that rural households’ expenditure on durable goods has increased from 3.1 per cent (1987-88) to 4.8 per cent (2009-10) while that of urban households increased from 4.1 per cent (1987-88) to 6.7 per cent (2009-10). Moreover, to get a better notice of trends emerging on consumption expenditure (NSSO) has decided to release monthly per capita expenditure survey on a quarterly basis.

 

Retail in India

Indian retail business values at around US$ 550 billion as of now and about four per cent of it accounts for the organised sector. A report by Boston Consulting Group (BCG) has revealed that the country’s organised retail is estimated at US$ 28 billion with around 7 per cent penetration. It is projected to become a US$ 260 billion business over the next decade with around 21 per cent penetration.

Today, Indian retail industry is represented by glamorous and spacious malls. Organised retail, whose growth is marked by the entry of formats like departmental stores, hypermarkets, supermarkets, specialty stores and western-style malls, is changing the conventional shopping norms of the traditional unorganised outlets.

India has been ranked as the fourth most attractive nation for retail investment among 30 emerging markets by the US-based global management consulting firm, A T Kearney, in its Global Retail Development Index (GRDI) 2011.

Cumulative foreign direct investment (FDI) inflows in single-brand retail trading during April 2000 to August 2011 stood at US$ 44.45 million, according to the Department of Industrial Policy and Promotion (DIPP).

Certain developments and investments that took place on the Indian retail canvas recently are discussed below-

• Real estate major DLF’s subsidiary DLF Brands has struck a deal with Chicago-based Claire’s Stores Inc to bring the latter to India and open its 75 stores over 2011-16. Claire’s is a specialty retailer which targets young girls through over 3,000 stores globally.
• French retail chain, Carrefour is on an expansion spree in India wherein it is about to finalise lease deals across 10 to 12 sites in the country to open cash-and-carry (wholesale) outlets.
• The world’s largest retailer Walmart will open an innovation lab in Bangalore by the end of 2011. The lab would be tasked to drive the US$ 422-billion company’s next generation innovations that impact shopping behavior among the customers.

 

Fast Moving Consumer Goods

Fast moving consumer goods (FMCG) sector is scaling new heights due to the entry of foreign brands and development of organised retailing in a big way. Indian packaged food industry, which is currently estimated at around US$ 10 billion, is driving retail sales to a major extent in India. FMCG firms have also started tapping net savvy consumers to give a boost to their revenue. Companies, including Dabur, Himalaya Herbal Healthcare, Neutrogena, Oriflame, Amul, Future Group, Aditya Birla Retail, REI Agro and Carrefour are making efforts to expand their reach through internet.

A recent study has revealed that lesser developed eastern states such as Bihar, Orissa, Chhattisgarh and Assam are leading rural sales in India. The analysis has strengthened the fact that rural markets are driving consumption of FMCG products.

• US FMCG giant McCormick, that has recently formed a joint venture (JV) with Indian basmati rice brand Kohinoor Foods, intends to tap Indian packaged food industry and achieve sales of US$ 85 million in the first year of operations in the country.
• FMCG firm GSK Consumer Healthcare (GSKCH) has made a debut into Indian breakfast cereal market by launching oats cereal under its flagship brand ‘Horlicks’. The breakfast cereal market in India is currently dominated by PepsiCo and Kellogg’s.
• Oral and dental hygiene products manufacturer Colgate Palmolive has decided to invest Rs 200 crore (US$ 40 million) to establish a greenfield facility at an upcoming industrial estate in Sanand which is being developed by state-run Gujarat Industrial Development Corporation (GIDC).

 

Indian Luxury Market

Luxury brands market in India grew at a healthy 20 per cent during 2010 reaching a size of US$ 5.8 billion, revealed a report by CII-AT Kearney on Indian Luxury. The report further stated that the Indian luxury market stood at a value of US$ 4.76 billion in 2009 and is anticipated to be worth US$ 14.7 billion by 2015.

Where on one hand the luxury electronics and car segments registered a growth of over 35 per cent, fine dining grew by almost 40 per cent in this 2010. Apparel and accessories, watches and personal care witnessed a substantial growth rate, between 24-30 per cents.

Similarly, India has surpassed the US to become the third largest men’s luxury jewellery market in the world in 2011, stated the researcher Euromonitor International. The researcher’s study projected Indian men’s jewellery market at Rs 954 crore (US$ 194.4 million) in terms of sales and made an anticipation for it to grow 36.4 per cent in 2012.

 

Online Shopping Makes the Way

Indian retailers and consumer durables companies are joining the web bandwagon with India’s online shopping industry registering phenomenal growth of almost 100 per cent annually. India has more than 100 million internet users, out of which around half of them are up for online purchases and the statistics is growing every year, says Google. Furthermore, the Indian online retail industry would register annual growth rate of 35 per cent to increase from current size of Rs 2, 000 crore (US$ 400.12 million) to Rs 7,000 crore (US$ 1.4 billion) by 2015, according to a leading industry body.

The US$ 10 billion Indian e-commerce market is expanding exponentially (it grew 47 per cent in 2011 to reach the present size) as rising internet penetration is making customers buy more and more stuff online. Investors are also betting high in the industry; they poured around US$ 200 million into Indian e-commerce start-ups in last couple of years.

Retail brands are expected to bring a great transformation in online space. Women’s apparel retail brand Biba and tyre brand Bridgestone have become available online recently. Internet and Mobile Association of India (IAMAI) expects online advertising to increase by 30-40 per cent in 2011-12 on back of increased internet usage by retailers.

 

Government Initiatives

At present, India allows 51 per cent foreign direct investment (FDI) in single-brand retail and 100 per cent in cash and carry format of the business. Meanwhile, the government has indicated an ‘early’ decision on opening multi-brand retail to foreign investment.

Furthermore, seeing the expansion of luxury brands market in India, the government is considering raising FDI bar to 100 per cent from current 51 per cent in single-brand retailing. The proposal has been placed before a joint government-industry task force for consultation.

 

Road Ahead

The Business Monitor International (BMI) India Retail Report for the fourth-quarter of 2011 released forecasts that the total retail sales will grow from US$ 411.28 billion in 2011 to US$ 804.06 billion by 2015. The report has underlined factors like economic growth, population expansion, increasing wealth of individuals and rapid construction of organised retail infrastructure as major drivers for the optimistic forecast figures.

The Indian healthcare industry will touch US$ 238.76 billionby 2020

India is poised to record additionalprogress in its economy after the slump that astounded almost all the keymarkets around the globe, the initial signs andfinancial report all presenting anoptimisticascending trend. The risingreputation of India on the transnationalground is one of the major reasons that have prompted a rise in the number of foreign tourists and corporate visitors in the country, thereby giving a boost to the various sectors in the economy which also includes healthcare and medical tourism sectors.

It has been clearly suggested that the healthcare sector will transform into a major sector that will fuel the economic growth and largely contribute to increased revenues, along with IT Services and Education sectors by the All India Management Association in collaboration with Boston Consulting Group and the Confederation of Indian Industries (CII) together in their “India’s New Opportunities- 2020″. Also, the report further suggests that these new opportunities are expected to create 40 million new jobs and around 200 billion increased revenues by the end of 2020.

Healthcare – Market Size

The Indian healthcare industry is witnessing growth at a rapid pace and it is expected that the sector . A number of major players in the healthcare sector are actively participating in the growth through expansion plans and putting in huge investments in Healthcare sector in the country. According to the Investment Commission of India the healthcare industry in India has experienced remarkableevolution of an added 12 per cent per year during the last 4 years driven by a number of factors such as increase in the average life expectancy and average income levels, and rising awareness for health insurance among consumers.

Healthcare – Trends and Investments

National Health Regulatory and Development Authority, NHRDA, with enforcement and complaint redressal powers, will oversee contracts, sanction health care service suppliers, improved decent standards for care delivery, implement patient’s charter of rights and take other measures to provide universal healthcare, according to the panels’ study.

Life Healthcare, South Africa’s second-largest hospital chain, is acquiring a 26 per cent stake in Analjit Singh-led Max Healthcare, making this one of the largest foreign investment deals in the Indian healthcare sector. The US$ 1.1 billion Life Healthcare, which operates 63 facilities with 8,322 beds in South Africa and Botswana, willprovide strategic inputs to the Indian venture, but will not actively participate in the management of the company. In the last few years, healthcare chains such as Parkway and funds such as Avenue Capital, Apax Partners and Warburg Pincus have invested in the US$ 65 billion Indian healthcare sector.

Fortis Healthcare (India) will acquire Singapore-based Fortis Healthcare International, privately-owned by the Indian company’s founders, for US$ 665 million.In September, the Indian hospital chain operator announced its plan to buy Fortis Healthcare International, to bring the group’s entire healthcare business under one entity.

LITHA Healthcare, the fourth-largest pharmaceutical company on the Johannesburg Stock Exchange (JSE), has entered into a strategic tie-up with NatcoPharma, a Hyderabad-based generic pharmaceutical manufacturer. Under the new agreement, Litha’s new generics business marketing a range of products developed and manufactured by the Indian company in South Africa (SA) and neighbouring states. The Natco agreement is the second-major generics link-up between Indian and SA pharmaceutical companies. Indian pharma giant Cipla already enjoys a very successful relationship with CiplaMedpro, the third-largest pharmaceutical company on the JSE.

Medical Tourism

Medical tourism is one of the foremost external drivers of evolution of the Indianhealthcare industry. India has emerged as a destination for medical tourism which serves its consumers with well educated, English-speaking medical staff, state-of-theartprivate hospitals and diagnostic conveniences, and comparatively low cost toaddress the high healthcare costs of the western world. India providesbest-in-class treatment, in some cases at very low prices as compared to countries like USA, and UK. India’s private hospitals excel in fields suchas cardiology, joint replacement, orthopaedic surgery, gastroenterology,ophthalmology, transplants and urology.

To capitalize on medical tourism and build a sustained public-privatepartnership in the hospital industry, the Government of India is supporting aninitiative to build a “Medi City”in Gurgaon, Haryana, on the outskirts of New Delhi. The compound will include a 900-bedhospital that supports 17 super specialties, a medical college and paramedicalcollege. The project, on 43 acres of land, will cost an estimated US$ 493 million. The Medi City will integrate allopathic care with alternative treatments,including unani, ayurvedic and homeopathic medicine, and it will providetelemedicine services as well.

Healthcare – Government Initiatives

There have been a number of striking initiatives taken up by the Government of Indiafor the enhancement of the healthcare sector in the country. These initiatives center on investment that are closely linked to providing better medical infrastructure, rural health facilities etc.

• 100 per cent foreign direct investment (FDI) is permitted for health and medical services under the automatic route
• The National Rural Health Mission (NHRM) had allocated US$ 10.15 billion for the up gradation and capacity enhancement of healthcare facilities
• Moreover, in order to meet revised cost of construction, in March 2010 the Government allocated an additional US$ 1.2 billion for six upcoming AIIMS-like institutes and upgradation of 13 existing Government Medical Colleges

Road Ahead

India’s thriving economy is driving urbanization and creatingan expanding middle class, with more disposable income to spend onhealthcare.The Government of India in association has developed an all-inclusive policy on healthcare which aims to achieve a remarkable growth for the sector which has led to a high number of compelling opportunities such as developingnew infrastructure and providing novel medical equipment solutions for the Indian sector. The sector holds enormous potential which is waiting to be unleashed to the maximum potential.